Bank Of Nova Scotia Merck & Co., Inc. Transaction History
Bank Of Nova Scotia
- $47.5 Billion
- Q1 2024
A detailed history of Bank Of Nova Scotia transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 913,268 shares of MRK stock, worth $115 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
913,268
Previous 3,144,632
70.96%
Holding current value
$115 Million
Previous $343 Million
64.85%
% of portfolio
0.25%
Previous 0.67%
Shares
13 transactions
Others Institutions Holding MRK
# of Institutions
3,762Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.5 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.7 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.8 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.08 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $318B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...